Press Tag: Scioto Biosciences

Scioto Biosciences, Inc. Announces Top-Line Results of SB-121 in a Phase Ib Trial in Patients Diagnosed With Autism Spectrum Disorder
Scioto Biosciences, Inc. Announces First Patient Dosed in Phase Ib Study in Patients Diagnosed with Autistic Disorder
Scioto Biosciences: Fortune Term Sheet — Tuesday, May 22
Fortune Term Sheet
Nationwide Children’s Spinoff Fighting Infection in Premature Babies Raises $1.8M
Columbus Business First